Related Experiment Video
Updated: Apr 19, 2026

Spectral Confocal Imaging of Fluorescently tagged Nicotinic Receptors in Knock-in Mice with Chronic Nicotine Administration
Published on: February 10, 2012
Differential expression of the beta4 neuronal nicotinic receptor subunit affects tolerance development and nicotinic
Erin E Meyers1, Esteban C Loetz1, Michael J Marks2
1Institute for Behavioral Genetics, 447 UCB, University of Colorado Boulder, Boulder, CO 80309, USA.
Abstract:
The role of neuronal nicotinic acetylcholine receptors (nAChR) containing the β4 subunit in tolerance development and nicotinic binding site levels following chronic nicotine treatment was investigated. Mice differing in expression of the β4-nAChR subunit [wild-type (β4(++)), heterozygote (β4(+-)) and null mutant (β4(--))] were chronically treated for 10 days with nicotine (0, 0.5, 1.0, 2.0 or 4.0mg/kg/h) by constant intravenous infusion. Chronic nicotine treatment elicited dose-dependent tolerance development. β4(--) mice developed significantly more tolerance than either β4(++) or β4(+-) mice which was most evident following treatment with 4.0mg/kg/h nicotine. Subsets of [(125)I]-epibatidine binding were measured in several brain regions. Deletion of the β4 subunit had little effect on initial levels of cytisine-sensitive [(125)I]-epibatidine binding (primarily α4β2-nAChR sites) or their response (generally increased binding) to chronic nicotine treatment. In contrast, β4 gene-dose-dependent decreases in expression 5IA-85380 resistant [(125)I]-epibatidine binding sites (primarily β4*-nAChR) were observed. While these β4*-nAChR sites were generally resistant to regulation by chronic nicotine treatment, significant increases in binding were noted for habenula and hindbrain. Comparison of previously published tolerance development in β2(--) mice (less tolerance) to that of β4(--) mice (more tolerance) supports a differential role for these receptor subtypes in regulating tolerance following chronic nicotine treatment.
Insights
Mice lacking the β4 subunit of neuronal nicotinic acetylcholine receptors (nAChR) showed increased nicotine tolerance. This highlights the β4 subunit
Area of Science:
- Neuroscience
- Pharmacology
- Genetics
Background:
- Neuronal nicotinic acetylcholine receptors (nAChRs) are implicated in nicotine addiction and tolerance.
- The β4 subunit is a key component of certain nAChR subtypes, but its specific role in nicotine tolerance is not fully understood.
Purpose of the Study:
- To investigate the role of the β4 subunit of nAChRs in the development of nicotine tolerance.
- To examine the impact of chronic nicotine treatment on nAChR binding sites in mice with varying β4 subunit expression.
Main Methods:
- Chronic nicotine administration via intravenous infusion to wild-type, heterozygous, and β4 subunit null mutant mice.
- Assessment of dose-dependent nicotine tolerance.
- Quantification of [(125)I]-epibatidine binding sites in various brain regions to measure nAChR levels.
Main Results:
- Mice lacking the β4 subunit (β4(--)) exhibited significantly greater nicotine tolerance compared to wild-type (β4(++)) and heterozygous (β4(+-) ) mice.
- Deletion of the β4 subunit led to decreased expression of 5IA-85380 resistant [(125)I]-epibatidine binding sites (primarily β4*-nAChR).
- Cytisine-sensitive [(125)I]-epibatidine binding sites (primarily α4β2-nAChR) showed minimal changes in response to β4 subunit deletion or chronic nicotine treatment.
Conclusions:
- The β4 subunit plays a critical role in regulating nicotine tolerance, with its absence exacerbating tolerance development.
- Different nAChR subtypes containing the β4 subunit (β4*-nAChR) are differentially regulated and contribute uniquely to nicotine tolerance compared to α4β2-nAChR sites.
Related Concept Videos
Cholinergic Receptors: Nicotinic
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
Adrenergic Receptors: β Subtype
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Desensitization and Tachyphylaxis
Neurochemical Transmission: Sites of Drug Action

